Clinical Trial

Phase II Clinical Study of HRS-9057 Injection in Patients With Heart Failure-induced Fluid Retention

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated June 1, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
Phase II clinical study of HRS-9057 injection in patients with heart failure-induced fluid retention
Protocol Amendment History 1 change
notable Enrollment increased: 118 -> 153 participants 2026-04-10
Trial Details
NCT Number NCT07318103
Lead Sponsor Fujian Shengdi Pharmaceutical Co., Ltd.
Conditions Fluid Retention Caused by Heart Failure
Enrollment 153 participants
Start Date 2025-12-31
Primary Completion 2026-07 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2026-06-01